Cato Institute
1000 Massachusetts Ave, NW
Washington, DC 20001-5403
 Phone (202) 842 0200
Fax (202) 842 3490
 Contact Us
Support Cato

Drug Reimportation: Time for a Free Market?

HILL BRIEFING
Friday, October 31, 2003
12:00 pm

Featuring Sen. Byron L. Dorgan (D-ND); and Roger Pilon, Vice President for Legal Affairs, Cato Institute.

253 Russell Senate Office Building


tv Watch the Event in Real Video
Listen to the Event in Real Audio (Audio Only)

Americans look abroad and see prescription drugs, made in the United States, sold at a small fraction of the price they’re paying here for the same drugs. Yet they can’t order such drugs legally because American law forbids the “reimportation” of drugs. That ban enables American drug manufacturers to recover their full costs, including high research and development costs, in the domestic market, then sell abroad to socialized medical systems at far below true cost. In effect, as with defense, the rest of the world is riding free while Americans pick up the full costs of drug R&D. Is it time for a free market in prescription drugs? And will opening the market to allow reimportation from Canada only, a compromise some people are proposing, lower prices for Americans, or simply raise them for Canadians?

Cato Institute • 1000 Massachusetts Avenue, N.W. • Washington D.C. 20001-5403
Phone (202) 842-0200 • Fax (202) 842-3490